Unknown

Dataset Information

0

Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects.


ABSTRACT: Osteosarcoma is an extremely malignant tumor, and its pathogenesis is complex and remains incompletely understood. Most cases of osteosarcoma are accompanied by symptoms of bone loss or result in pathological fractures due to weakened bones. Enhancing the survival rate of osteosarcoma patients has proven to be a long-standing challenge. Numerous studies mentioned in this paper, including in-vitro, in-vivo, and in-situ studies have consistently indicated a close association between the symptoms of bone loss associated with osteosarcoma and the presence of osteoclasts. As the sole cells capable of bone resorption, osteoclasts participate in a malignant cycle within the osteosarcoma microenvironment. These cells interact with osteoblasts and osteosarcoma cells, secreting various factors that further influence these cells, disrupting bone homeostasis, and shifting the balance toward bone resorption, thereby promoting the onset and progression of osteosarcoma. Moreover, the interaction between osteoclasts and various other cells types, such as tumor-associated macrophages, myeloid-derived suppressor cells, DCs cells, T cells, and tumor-associated fibroblasts in the osteosarcoma microenvironment plays a crucial role in disease progression. Consequently, understanding the role of osteoclasts in osteosarcoma has sparked significant interest. This review primarily examines the physiological characteristics and functional mechanisms of osteoclasts in osteosarcoma, and briefly discusses potential therapies targeting osteoclasts for osteosarcoma treatment. These studies provide fresh ideas and directions for future research on the treatment of osteosarcoma.

SUBMITTER: Gao YM 

PROVIDER: S-EPMC10661907 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects.

Gao Yi-Ming YM   Pei Yan Y   Zhao Fei-Fei FF   Wang Ling L  

Cancer management and research 20231117


Osteosarcoma is an extremely malignant tumor, and its pathogenesis is complex and remains incompletely understood. Most cases of osteosarcoma are accompanied by symptoms of bone loss or result in pathological fractures due to weakened bones. Enhancing the survival rate of osteosarcoma patients has proven to be a long-standing challenge. Numerous studies mentioned in this paper, including in-vitro, in-vivo, and in-situ studies have consistently indicated a close association between the symptoms o  ...[more]

Similar Datasets

| S-EPMC9310545 | biostudies-literature
| S-EPMC11298875 | biostudies-literature
| S-EPMC6103456 | biostudies-literature
| S-EPMC9511185 | biostudies-literature
| S-EPMC7367382 | biostudies-literature
| S-EPMC7866157 | biostudies-literature
| S-EPMC5483461 | biostudies-other
| S-EPMC6826337 | biostudies-literature
| S-EPMC9532003 | biostudies-literature
| S-EPMC4492683 | biostudies-literature